Minafin has strengthened the industrial and commercial base of its healthcare chemicals division with the acquisition of Delmar in Montreal, Canada. This operation enables Minakem to establish itself on North American soil for the first time in its history, with a site approved by U.S. and international drug agencies for the manufacture of active pharmaceutical ingredients (APIs) by organic synthesis. Delmar also brings an important portfolio of generic active ingredients, which will accelera...